Gender-related changes of the epicardial fat thickness and leptin in obstructive sleep apnea

Echocardiography

Volumn 31, Issue 4, 2014, Pages 411-419

  Akilli, Hakan ^a   Kayrak, Mehmet ^a   Bekci, Taha Tahir ^b   Erdogan, Halil Ibrahim ^a   Aribas, Alpay ^a   Yildirim, Oguzhan ^a   Taner, Alpaslan ^c   Erer, Murat ^a   Unlu, Ali ^d  

^a NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^b Department of Pulmonary Medicine Konya Education and Research Hospital ^*  (Turkey)

^c Section of Pediatric Surgery   (Turkey)

^d SELCUK UNIVERSITY   (Turkey)

Author keywords

epicardial fat; gender; leptin; obstructive sleep apnea

Indexed keywords

LEPTIN; BIOLOGICAL MARKER;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ECHOCARDIOGRAPH; ECHOCARDIOGRAPHY; EPICARDIAL FAT THICKNESS; EPICARDIUM; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; ADIPOSE TISSUE; BLOOD; BODY MASS; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPLICATION; DOPPLER ECHOCARDIOGRAPHY; FOLLOW UP; METABOLISM; MIDDLE AGED; OBESITY; PATHOLOGY; PERICARDIUM; PROCEDURES; PROSPECTIVE STUDY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; SLEEP APNEA, OBSTRUCTIVE;

ADIPOSE TISSUE; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPTIN; MALE; MIDDLE AGED; OBESITY; PERICARDIUM; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84898016816     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/echo.12392     Document Type: Article

References (49)

1. Douglas NJ, Polo O,: Pathogenesis of obstructive sleep apnoea/hypopnoea syndrome. Lancet 1994; 344: 653-655.
2. Phillipson EA,: Sleep apnea-A major public health problem. N Engl J Med 1993; 328: 1271-1273.
3. Andreas S, Schulz R, Werner GS, et al. Prevalence of obstructive sleep apnoea in patients with coronary artery disease. Coron Artery Dis 1996; 7: 541-545.
4. Mohsenin V,: Sleep-related breathing disorders and risk of stroke. Stroke 2001; 32: 1271-1278.
5. Lavie P, Herer P, Hoffstein V,: Obstructive sleep apnoea syndrome as a risk factor for hypertension: Population study. BMJ 2000; 320: 479-482.
6. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19-25.
7. Baldwin CM, Griffith KA, Nieto FJ, et al. The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep 2001; 24: 96-105.
8. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235.
9. O'Donnell CP, Schwartz AR, Smith PL,: Upper airway collapsibility: The importance of gender and adiposity. Am J Respir Crit Care Med 2000; 162: 1606-1607.
10. Shamsuzzaman AS, Gersh BJ, Somers VK,: Obstructive sleep apnea: Implications for cardiac and vascular disease. JAMA 2003; 290: 1906-1914.
11. Meier U, Gressner AM,: Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50: 1511-1525.
12. Ozturk L, Unal M, Tamer L, et al. The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg 2003; 129: 538-540.
13. Basoglu OK, Sarac F, Sarac S, et al. Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med 2011; 6: 120-125.
14. Ulukavak Ciftci T, Kokturk O, Bukan N, et al. Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome. Respiration 2005; 72: 395-401.
15. Harsch IA, Konturek PC, Koebnick C, et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: Effect of CPAP treatment. Eur Respir J 2003; 22: 251-257.
16. Tokuda F, Sando Y, Matsui H, et al. Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome. Intern Med 2008; 47: 1843-1849.
17. Tatsumi K, Kasahara Y, Kurosu K, et al. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest 2005; 127: 716-721.
18. Kapsimalis F, Varouchakis G, Manousaki A, et al. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. Lung 2008; 186: 209-217.
19. Schafer H, Pauleit D, Sudhop T, et al. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002; 122: 829-839.
20. Sanchez-de-la-Torre M, Mediano O, Barcelo A, et al. The influence of obesity and obstructive sleep apnea on metabolic hormones. Sleep Breath 2012; 16: 649-656.
21. Barcelo A, Barbe F, Llompart E, et al. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: Role of obesity. Am J Respir Crit Care Med 2005; 171: 183-187.
22. Ursavas A, Ilcol YO, Nalci N, et al. Ghrelin, leptin, adiponectin, and resistin levels in sleep apnea syndrome: Role of obesity. Ann Thorac Med 2010; 5: 161-165.
23. Grunstein R, Wilcox I, Yang TS, et al. Snoring and sleep apnoea in men: Association with central obesity and hypertension. Int J Obes Relat Metab Disord 1993; 17: 533-540.
24. Okorodudu DO, Jumean MF, Montori VM, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: A systematic review and meta-analysis. Int J Obes (Lond) 2010; 34: 791-799.
25. Hamdy O, Porramatikul S, Al-Ozairi E,: Metabolic obesity: The paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006; 2: 367-373.
26. Iacobellis G, Willens HJ,: Echocardiographic epicardial fat: A review of research and clinical applications. J Am Soc Echocardiogr 2009; 22: 1311-1319; quiz 1417-1318.
27. Nabati M, Saffar N, Yazdani J, et al. Relationship between epicardial fat measured by echocardiography and coronary atherosclerosis: A single-blind historical cohort study. Echocardiography 2013; 30: 505-511.
28. Mariani S, Fiore D, Barbaro G, et al. Association of epicardial fat thickness with the severity of obstructive sleep apnea in obese patients. Int J Cardiol 2013; 167: 2244-2249.
29. Lubrano C, Saponara M, Barbaro G, et al. Relationships between body fat distribution, epicardial fat and obstructive sleep apnea in obese patients with and without metabolic syndrome. PLoS One 2012; 7: e47059.
30. Balta S, Demirkol S, Kucuk U, et al. Epicardial adipose tissue should be evaluated with other inflammatory markers in patients with subclinical hypothyroidism. Med Princ Pract 2013 Apr 6 [Epub ahead of print].
31. Sleep-related breathing disorders in adults recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-689.
32. Quinones MA, Otto CM, Stoddard M, et al. Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167-184.
33. Kelesidis T, Kelesidis I, Chou S, et al. Narrative review: The role of leptin in human physiology: Emerging clinical applications. Ann Intern Med 2010; 152: 93-100.
34. Correia ML, Rahmouni K,: Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome. Diabetes Obes Metab 2006; 8: 603-610.
35. Thomas T, Burguera B, Melton LJ III, et al. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism 2000; 49: 1278-1284.
36. Butt M, Dwivedi G, Khair O, et al. Obstructive sleep apnea and cardiovascular disease. Int J Cardiol 2010; 139: 7-16.
37. Li C, Ford ES, Zhao G, et al. Prevalence of self-reported clinically diagnosed sleep apnea according to obesity status in men and women: National Health and Nutrition Examination Survey, 2005-2006. Prev Med 2010; 51: 18-23.
38. Young T, Peppard PE, Gottlieb DJ,: Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med 2002; 165: 1217-1239.
39. Rabkin SW,: Epicardial fat: Properties, function and relationship to obesity. Obes Rev 2007; 8: 253-261.
40. Lemieux S, Prud'homme D, Bouchard C, et al. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 1993; 58: 463-467.
41. Horner RL, Brooks D, Kozar LF, et al. Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs. J Appl Physiol 1995; 79: 151-162.
42. Blaak E,: Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 2001; 4: 499-502.
43. Richelsen B,: Increased alpha 2- but similar beta-adrenergic receptor activities in subcutaneous gluteal adipocytes from females compared with males. Eur J Clin Invest 1986; 16: 302-309.
44. Wahrenberg H, Lonnqvist F, Arner P,: Mechanisms underlying regional differences in lipolysis in human adipose tissue. J Clin Invest 1989; 84: 458-467.
45. Jensen MD, Cryer PE, Johnson CM, et al. Effects of epinephrine on regional free fatty acid and energy metabolism in men and women. Am J Physiol 1996; 270: E259-E264.
46. Lai YH, Yun CH, Yang FS, et al. Epicardial adipose tissue relating to anthropometrics, metabolic derangements and fatty liver disease independently contributes to serum high-sensitivity C-reactive protein beyond body fat composition: A study validated with computed tomography. J Am Soc Echocardiogr 2012; 25: 234-241.
47. Balta S, Demirkol S, Kucuk U, et al. Epicardial fat thickness and cardio-ankle vascular index without other inflammatory markers may not provide information to clinicians about the systemic inflammation. Cardiology 2013; 125: 13-14.
48. Dudenbostel T, Calhoun DA,: Resistant hypertension, obstructive sleep apnoea and aldosterone. J Hum Hypertens 2012; 26: 281-287.
49. De Haro Moraes C, Figueiredo VN, De Faria AP, et al. High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension. J Hum Hypertens 2012; 5: 9-80.